tbuckley/cabot-search huggingface dataset:
Different T-Cell Activation Approaches Impact the Resulting CART-Cell Products and Possible Clinical Outcomes
Authors: Biping Deng, Zhaoli Liu, Xiaoming Qu, Yu'e Zhang, Zhongxin Zhang, Rong Luan, Lingli Zhang, Ming Ma, Xiai Wu, Rui Liu, Alex H. Chang, Kai Hu, Chunrong Tong
Journal: Blood (2024)
Characterization of Sole Loss of the Y Chromosome and Associated Effects on Adaptive Immunity in Adult Male Patients with Acute Myeloid Leukemia (AML)
Authors: Maria Velegraki, Cankun Wang, Deedra Nicolet, Krzysztof Mrózek, Payton Weltge, Ethan Hamp, Jill Buss, Andrea Laganson, Christopher C. Oakes, Jordan Krull, John C. Byrd, Richard M. Stone, Qin Ma, Ann-Kathrin Eisfeld, Zihai Li
Journal: Blood (2024)
Correlation of ELN-Risk and Gene Mutations with Quizartinib Efficacy in Patients with <i>FLT3</i>-ITD-Negative Newly Diagnosed Acute Myeloid Leukemia in the Phase 2 Quiwi Pethema Trial
Authors: David Martinez-Cuadron, Rebeca Rodriguez-Veiga, Juan Miguel Bergua Burgues, Jesús Lorenzo Algarra, Carmen Botella, Jose Antonio Pérez-Simón, Teresa Bernal Del Castillo, Mar Tormo, Maria Calbacho, Olga Salamero, Josefina Serrano, Victor Noriega Concepcion, Juan Antonio Lopez Lopez, Susana Vives, Jose Luis Lopez Lorenzo, Mercedes Colorado, Maria Vidriales Vicente, Raimundo Garcia Boyero, Maria Teresa Olave Rubio, Pilar Herrera, Olga Arce, Manuel Barrios Garcia, Maria Jose Sayas Lloris, Marta Polo, Maria Isabel Gómez Roncero, Eva Barragán, Rosa Ayala, Carmen Chillon, Maria Jose Calasanz, Bruno Paiva, Blanca Boluda, Ignacio Casas Aviles, Pilar Lloret Madrid, Claudia Sargas, María-José Sánchez-Sánchez, Carlos Rodríguez-Medina, Laida Cuevas Palomares, Júlia Morán Sánchez, M Carmen Mateos Rodríguez, Matxalen Olivares Salaverri, Maria Del Carmen Martinez Chamorro, Natalia Alonso Vence, Sandra Suarez Ordonez, Irene Sanchez Vadillo, María Solé-Rodríguez, Bernardo Javier González González, Antonio Martinez Frances, Rebeca Cuello, Alfonso Fernández Fernández, Jorge Labrador, Pau Montesinos
Journal: Blood (2024)
Nemtabrutinib, a Noncovalent Reversible BTK Inhibitor in Relapsed or Refractory Marginal Zone Lymphoma: Results from the Phase 2 Bellwave-003 Study
Authors: Pier Luigi Zinzani, Juan Carlos Dupont, Alessandra Tucci, Jing Yang, Yan Xu, Siyang Leng, Muhit Ozcan
Journal: Blood (2024)
A Phase II Study of Cladribine, Idarubicin, and Cytarabine (CLIA) in Combination with Gilteritinib for Patients with Newly Diagnosed <i>FLT3</i>-Mutated Acute Myeloid Leukemia
Authors: Hannah Goulart, Hagop M. Kantarjian, Naval Daver, Musa Yilmaz, Guillermo Garcia-Manero, Kelly S. Chien, Jan A. Burger, Naveen Pemmaraju, Courtney D. DiNardo, Nicholas J. Short, Guillermo Montalban-Bravo, Abhishek Maiti, Danielle Hammond, Ghayas C. Issa, Elias Jabbour, Farhad Ravandi, Tapan M. Kadia
Journal: Blood (2024)
Rocbrutinib, a New-Generation BTK Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Non-GCB Diffuse Large B Cell Lymphoma
Authors: Yuqin Song, Qingqing Cai, Keshu Zhou, Ming Jiang, Zhengming Jin, Lei Zhang, Xiuhua Sun, Haiyan Yang, Lanfang Li, Kaiyang Ding, Junyuan Qi, Hongmei Jing, Wei Yang, Min Zhou, Jun Ma, Zhigang Peng, Wei Xu, Hui Zhou, Li Yu, Yuankai Shi, Guohui Cui, Zheng Wang, Nawei Liu, Yejiang Lou, Yue Shen, Yi Chen, Fenlai Tan, Jun Zhu
Journal: Blood (2024)
Venetoclax, Azacitidine, Combined with Low-Dose Cytarabine in Older Newly Diagnosed Acute Myeloid Leukemia：the Result of a Prospective, Multicenter, Open, Randomized Controlled Trials
Authors: Xiao Han, Hai Yi, Hongju Yan, Ying Zhang, Yun Luo, Yue Xiao, Mengyun Zhang, Liang Fang, Guo Chen, Zhiyuan Peng, Kai Wan, Xu Tan, Xiannian Qin, Maihong Wang, Siyu Chen, Yingying Ma, Hong Liu, Cheng Zhang, Qin Wen, Xi Zhang
Journal: Blood (2024)
Hematopoietic Bias Drives Lymphopenia in Myeloproliferative Neoplasms
Authors: Daniel C Choi, Nassima Messali, Ghaith Abu-Zeinah, Pouneh Kermani, Maria Mia Yabut, Franco Castillo Tokumori, Katie Erdos, Joseph M. Scandura, Narasimha Rao Uda, Heidi Lischer, Thomas Lehmann, Marta Sobas, Tata Nageswara Rao
Journal: Blood (2024)
CD45-Directed Radioimmunotherapy with the Alpha-Emitter Astatine-211 As Conditioning for Autologous Hematopoietic Stem/Progenitor Cell Gene Therapy: Results from a Nonhuman Primate Model
Authors: Stefan Radtke, Kyle Swing, George S. Laszlo, Andrea Repele, Greta N. Kanestrom, Nicholas E Petty, Donald K. Hamlin, D. Scott Wilbur, Brenda M. Sandmaier, Hans-Peter Kiem, Roland B. Walter
Journal: Blood (2024)
Predictive Markers for Outcomes after Disease Progression Post BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma
Authors: Fnu Amisha, Ziad Abuhelwa, Wenyi Fan, Doris K. Hansen, Omar Castaneda, Ciara Louise Freeman, Hien Liu, Frederick Locke, Taiga Nishihori, Ariel Grajales-Cruz, Brandon Blue, Kenneth H. Shain, Melissa Alsina, Rachid Baz
Journal: Blood (2024)
Global Burden and Trend of Burkitt Lymphoma in 38 OECD Countries from 1990-2021: A Benchmarking Global Analysis for the Gbd 2021
Authors: Adit Alpesh Dharia, Vishva M Patel, Kavya Maddineni, Shamitha Hejmadi, Dharmik Patel, Rutvik Raval, Suraj Kunhipurayil, Ishita Hirpara, Geethika Potluri, Dhruvi Modi, Dhruvkumar Gadhiya, Salman Muddassir, Hardik Dineshbhai Desai
Journal: Blood (2024)
Long-Term Benefits in Patient-Reported Outcomes and Time to Next Anti-Myeloma Therapy of Ciltacabtagene Autoleucel (Cilta-cel) Versus Standard of Care for Patients with Lenalidomide-Refractory Multiple Myeloma: Results from the Phase 3 Cartitude-4 Clinical Trial
Authors: Noffar Bar, Roberto Mina, Anne K. Mylin, Hisayuki Yokoyama, Hila Magen, Winfried Alsdorf, Monique C. Minnema, Leyla O. Shune, Iris Isufi, Simon J Harrison, Urvi A. Shah, André De Champlain, Katharine S. Gries, Diana Chen, Quanlin Li, Tzu-Min Yeh, Ana Slaughter, Carolina Lonardi, Nina Benachour, Arnab Ghosh, William Deraedt, Martin Vogel, Nikoletta Lendvai, Nitin Patel, Octavio Costa Filho, Erika Florendo, Lionel Karlin, Katja C. Weisel
Journal: Blood (2024)
FLAG IDA Venetoclax in Newly Diagnosed Pediatric and AYA Patients with AML
Authors: Reeja Raj, Samanta Catueno, Amber Gibson, David McCall, Miriam B. Garcia, Cesar Nunez, Michael E. Roth, Koji Sasaki, Priti Tewari, Branko Cuglievan, Courtney D. DiNardo
Journal: Blood (2024)
Short Diagnosis to Treatment Interval Is Associated with Poor Outcomes in Relapse or Refractory Diffuse Large B-Cell Lymphoma
Authors: Keita Ishii, Kazuhito Suzuki, Ryoko Fukushima, Tadahiro Gunji, Hiroto Ishii, Masaharu Kawashima, Hideki Uryu, Kurumi Tsukamoto, Kei Hirano, Riku Nagao, Hiroki Yokoyama, Atsushi Katsube, Susumu Tanoue, Yasutaka Mochizuki, Rie Ohba, Daiki Hattori, Mitsuji Katori, Takeshi Saito, Kaichi Nishiwaki, Nobuaki Dobashi, Shingo Yano
Journal: Blood (2024)
Targeting the IRE1α-XBP1s Pathway to Enhance Venetoclax Effectiveness in AML
Authors: Orsola Di Martino, Mary Basse, Nancy BJ Arthur, Nishanth Gabriel, Judith Sokei, Ahmed Mahmoud, Marco Vitale, Elena Masselli, Cecilia Carubbi, Stephen Sykes, Francesca Ferraro
Journal: Blood (2024)
The Role of Gut Microbiota in Modulating Efficacy and Adverse Effects of CAR T-Cell Therapy in the Pediatric Population
Authors: Zoe O'Connor, Ashley Bui, Laura Coughlin, Shuheng Gan, Samuel John, Nicole Poulides, Parastoo Sabaeifard, Xiaowei Zhan, Stephen Lim, Angelica Sanjuan, Theodore W. Laetsch, Andrew Y. Koh
Journal: Blood (2024)
Quantum-First: Effects of Quizartinib (Q) on RFS, OS, CIR, and MRD in Newly Diagnosed (nd) Patients (pts) with FMS-like Tyrosine Kinase 3-Internal Tandem Duplication-Positive (<i>FLT3</i>-ITD+) Acute Myeloid Leukemia (AML) Who Received Continuation (CONT) Therapy (tx)
Authors: Mark J. Levis, Harry Erba, Pau Montesinos, Elzbieta Patkowska, Jorge E. Cortes, Herve Dombret, Alexander E. Perl, Sergio Amadori, Jianxiang Wang, Richard F. Schlenk, Li Liu, Yasser M. Mostafa Kamel, Karima Imadalou, Abderrahmane Laadem, Mikkael A. Sekeres, Kristy Burns
Journal: Blood (2024)
Ziftomenib Combined with Venetoclax/Azacitidine in Relapsed/Refractory <i>NPM1</i>-m or <i>KMT2A</i>-r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007
Authors: Amir T. Fathi, Ghayas C. Issa, Eunice S. Wang, Harry Erba, Jessica Kaplan Altman, Suresh Kumar Balasubramanian, Gail J. Roboz, Gary J. Schiller, Christine M. McMahon, Neil D. Palmisiano, Mark B Juckett, Yazan F. Madanat, Marcello Rotta, Keith W. Pratz, George Yaghmour, Kalyan Nadiminti, Helen Wei, Marcie Riches, Daniel Corum, Mollie Leoni, Stephen Dale, Amer M. Zeidan
Journal: Blood (2024)
Inhibiting Tumor Cell CDK9 Reprograms Cell Death Pathways to Enhance Efficacy of CAR T Cell Therapy
Authors: Ciril Abraham, Wenbin Mo, Tien Bui, Mimi Chen, Yuanyuan Tian, Gennaro Clando, Morgan Chaunzwa, Ying WANG, Jozef Madzo, Jean-Pierre Issa, Yi Zhang
Journal: Blood (2024)
Developing Novel Cellular Therapies for Cutaneous T Cell Lymphoma (CTCL): Combining Immunopeptidomics and Endogenous T Cell (ETC) Therapy Platforms to Identify and Target Shared CTCL-Associated Antigens
Authors: Casey Bermack, Ke Pan, Yulun Chiu, Luis Malpica, Swaminathan P Iyer, Christopher R. Flowers, Cassian Yee
Journal: Blood (2024)
Real-World Management Patterns of Acute Toxicity Following Bispecific Antibody Therapy for Patients with B-Cell Lymphoma - the Geltamo (Spanish Lymphoma Group) Experience
Authors: Mariana Bastos-Oreiro, Gloria Iacoboni, Víctor Navarro Garces, Hugo Daniel Luzardo Henríquez, Maria Jose Rodriguez Salazar, Paula Fernández Caldas-González, Paula Fernández Caldas-González, Irene Medina, Pablo Manresa, Sonia González De Villambrosia, Antonio Gutierrez, Eva Donato, Maria Teresa Busnego Barreto, Norma C. Gutierrez, Javier López, Fernando Martín Moro, Ana García-Noblejas, Pilar Gómez, Samuel Romero, Ana Jiménez Ubieto, Elena Perez Ceballos, Belen Navarro, Lucia Villalon Blanco, María Angeles Goñi Herranz, Miguel Ángel Rodríguez Gil, Victoria Dourdil, Irati Ormazabal Vélez, Piva Sanchez Anton, Ramon Garcia-Sanz, Pau Abrisqueta Costa, Alejandro Martín García-Sancho
Journal: Blood (2024)
The Transcription Factor IRF8 Regulates the Sensitivity of AML Cells to LSD1 Inhibition and All-Trans Retinoic Acid
Authors: Emily E Hartung, Kanwaldeep Singh, Sarah Coopersmith, Jamie Avrumutsoae, Siddaarth Varatharajan, Sara Pishyar, Pradhariny Prabagaran, Dina Khalaf, Alejandro Garcia-Horton, Ronan Foley, Brian Leber, Irwin Walker, Kylie L. Lepic, Maria Kleppe, Hugh Young Rienhoff, Tobias Berg
Journal: Blood (2024)
Real World Evidence on Patient Reported Outcomes Among Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab-Based Regimens in Frontline (1L)
Authors: Smith Giri, Liton Francisco, Nicole Rafalko, Niodita Gupta-Werner, Joshua Richman, Smita Bhatia, Kelly Godby, Gayathri Ravi, Susan Bal, Marjohn Armoon, Rohan Medhekar, Luciano J. Costa
Journal: Blood (2024)
Household Poverty and Risk of Obesity during Maintenance Therapy for Childhood Acute Lymphoblastic Leukemia (ALL): Children's Oncology Group (COG) Study AALL03N1 Report
Authors: Karnika Mehrotra, Yanjun Chen, Joshua Richman, Lindsey Hageman, Wendy Landier, Smita Bhatia, Aman Wadhwa
Journal: Blood (2024)
Timing of Response with Gilteritinib Monotherapy in Relapsed or Refractory <i>FLT3</i>-Mutated Acute Myeloid Leukemia
Authors: Alexander E. Perl, Mark J. Levis, Andrew Wei, Hee-je Kim, June-won Cheong, Yu Zhang, Jian Li, Hisayuki Yokoyama, Naoko Hosono, Nahla Hasabou, Dina Elsouda, Jamie Jung-Hee An, Jianxiang Wang
Journal: Blood (2024)
Dissecting the Role of Acquired Regions of Homozygosity Detected By Microarray Along the Genome of a Large Cohort of Adult Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
Authors: Gianfranco Lapietra, Jordi Ribera, Mireia Morgades, Neus Ruiz Xiville, Anna Torrent, Mar Mallo, Jesus Maria Hernandez Rivas, Alberto Hernández Sánchez, Alberto Orfao, Isabel Granada, Jose Tomas Navarro, Ilaria Del Giudice, Maurizio Martelli, Sabina Chiaretti, Josep-Maria Ribera
Journal: Blood (2024)
Voxelotor Impact after 6 Months on Blood Rheology in Patients with Sickle Cell Disease
Authors: Gonzalo De Luna, Laura Bencheikh, Philippe Connes, Thomas D'Humieres, Philippe Le Corvoiser, Sihem Alouni, Jamila Alhamrouni, Raphaelle Arrouasse, Dalila Bitari, Anoosha Habibi, Fatima Bensiradj, Etienne Audureau, Vincent Malcor Deydier De Pierrefeu, PA Natella, Meghan Perkins, Laura Matabishi-Bibi, Caroline Barau, Marie Cambot, Pablo Bartolucci
Journal: Blood (2024)
Preclinical Development of a Novel Pan-RAS Inhibitor Against Relapsed/Refractory Multiple Myeloma
Authors: Jeremiah C. Pfitzer, Razan Waliagha, Linda B. Baughn, Adam B. Keeton, Xi Chen, Yulia Maxuitenko, Shaji Kumar, Brian Van Ness, Gary Piazza, Amit K Mitra
Journal: Blood (2024)
Inhibition of Endoplasmic Reticulum Associated Degradation Is Cytotoxic to Relapsed Refractory Multiple Myeloma through Altered Proapoptotic Signaling
Authors: Erin M Kropp, Sho Matono, Aaron Robida, Malathi Kandarpa, Olivia Wang, Andrew Alt, Moshe Talpaz, Matthew Pianko, Qing Li
Journal: Blood (2024)
Treatment and Outcome of ATL Diagnosed in 2021 to 2023 By the Kagoshima ATL Registry
Authors: Daisuke Nakamura, Satsuki Owatari, Takayoshi Miyazono, Hidetoshi Nakashima, Akihiko Arai, Hirosaka Inoue, Kentaro Yonekura, Kazuyuku Fujii, Shogo Takeuchi, Satoshi Fukutoku, Seiichiro Nakabeppu, Kodai Shima, Naosuke Arima, Yuhei Kamada, Koichi Haraguchi, Hideaki Kawada, Yoshikiyo Ito, Maki Otsuka, Shuichi Hanada, Makoto Yoshimitsu, Kenji Ishitsuka
Journal: Blood (2024)
Real-World Evidence of First-Line Therapy in Transplant Eligible Multiple Myeloma Patients: Insights from the Cimma Study
Authors: Maria-Victoria Mateos, Fernando Escalante, Natalia Marin Huarte, Angela Garcia Garcia-Porrero, Miguel Jesús Villanueva Forero, Rafael Rios Tamayo, Antonia Sampol Mayol, Eugenio Gimenez, Jose-Angel Hernandez Rivas, Savana Research Group, Joaquin Martinez Lopez
Journal: Blood (2024)
7-Day Venetoclax Combined with Intensive Chemotherapy As Induction Treatment in Newly Diagnosed Acute Myeloid Leukemia
Authors: Ting Liu, Xingli Zhao, Xiaohui Suo, Guanchen Bai, Yanliang Bai, Weihua Zhao, Hongling Peng, Fang Zheng, Dongmei Wang, Liyun Zhao, Jie Liu, Ling Li, Xinxiao Lu, Congcong Zhang, Sifeng Gao, Zeyan Shi, Yunya Luo, Xuemei Zhao, Yaxian Tan, ZePing Zhou, Pengxiang Guo, Yingchang Mi, Kaiqi Liu
Journal: Blood (2024)
Results from a Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Tebapivat (AG-946) in Patients with Sickle Cell Disease
Authors: Julia Z Xu, Enrico M Novelli, Jean-Antoine Ribeil, Andreas Glenthøj, Srila Gopal, Hanny Al-Samkari, Modupe Idowu, Jenny Despotovic, Spurthi Patil, Xiaoshu Dai, Abdullah Al Masud, Michael Callaghan, Fuad El Rassi
Journal: Blood (2024)
Real-World Clinical Outcomes in Patients Initiating Covalent Btki (cBTKi) with and without Incident Cardiovascular Adverse Events By Line of Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
Authors: David Dingli, Enrico De Nigris, Siyang Leng, Mohammed Z. H. Farooqui, Halit O. Yapici, Ian Weimer, Weiqi Jiao, Hayden W. Hyatt, Xuan Zhang, Kunal Lodaya, Mavis Obeng-Kusi
Journal: Blood (2024)
Multi-Omics Reveal Immune Microenvironment Alterations in Multiple Myeloma and Its Precursor Stages
Authors: Yan Cheng, Fumou Sun, Daisy V. Alapat, Visanu Wanchai, David E. Mery, Eric Siegel, Hongwei Xu, Sarah K. Johnson, Wancheng Guo, Clyde Bailey, Cody Ashby, Michael Anton Bauer, Samer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Guido Tricot, John D Shaughnessy, Jr, Fenghuang Zhan
Journal: Blood (2024)
Phase I/II Combination Study of Azacitidine and Venetoclax Post Hypomethylating Agents Failure in High Risk MDS and CMML
Authors: Julie Braish, Guillermo Montalban-Bravo, Farhad Ravandi, Nicholas J. Short, Tapan M. Kadia, Maro Ohanian, Kelly S. Chien, Lucia Masarova, Koji Sasaki, Musa Yilmaz, Naval Daver, Gautam Borthakur, Hagop M. Kantarjian, Guillermo Garcia-Manero
Journal: Blood (2024)
Predictors of Blast Transformation (BT) and Post-BT Survival in Chronic Myelomonocytic Leukemia (CMML)
Authors: Anuya A. Natu, Clifford M. Csizmar, Terra L. Lasho, Rashmi Kanagal-Shamanna, Sanam Loghavi, Alexandre Bazinet, Kelly S. Chien, Danielle Hammond, Christy Finke, Aref Al-Kali, Hassan B Alkhateeb, Naseema Gangat, Abhishek A. Mangaonkar, Antoine N. Saliba, Ayalew Tefferi, Guillermo Garcia-Manero, Hagop Kantarjian, Guillermo Montalban-Bravo, Mrinal M. Patnaik
Journal: Blood (2024)
Fixed-Duration Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Updated Results from Arm 1 of the Epcore NHL-5 Trial
Authors: Ronit Gurion, Irit Avivi Mazza, Catherine Thieblemont, Won Seog Kim, Andras Masszi, Alejandro Martín García-Sancho, Zsolt Nagy, Benoit Tessoulin, Ana Jimenez Ubieto, Po-Shen Ko, Daniel Alan Kerr, Edwin E. Jeng, Satya Siddani, Neha Joshi, Neha Dixit, Mariana Sacchi, Pegah Jafarinasabian, Abraham Avigdor
Journal: Blood (2024)
Peripheral Blood Stem Cell <i>Versus</i> Bone Marrow Graft for Non-T-Depleted Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Patients with Secondary Acute Myeloid Leukemia in First Complete Remission: A Study from the ALWP/EBMT
Authors: Arnon Nagler, Allain-Thibeault Ferhat, Didier Blaise, Yener Koc, Emanuele Angelucci, Alessandro Busca, Jiri Pavlu, Stefania Bramanti, Maija Itäla-remes, Maria Aranzazu Bermudez Rodriguez, Jan Vydra, Alexander Kulagin, Ali Bazarbachi, Bipin N. Savani, Fabio Ciceri, Mohamad Mohty
Journal: Blood (2024)
Comprehensive Analysis of KMT2A Alterations in Acute Myeloid Leukemia and Their Impact on Survival and Response Rates; A Single Center Experience
Authors: Ameed Bawwab, Daniel P. Nurse, Jessica El-Asmar, Yomna Abu-Farsakh, Moath Albliwi, John Hanna, Asad Rauf, Heya Batah, Hasan Abuamsha, Emily C. Zabor, Yohana B. Bedelu, Mark Jinan Chen, Joy Nakitandwe, Akriti G. Jain, John C. Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Sudipto Mukherjee, Anjali S. Advani, Hetty E. Carraway, Moaath K. Mustafa Ali
Journal: Blood (2024)
Development of the ASH Research Collaborative Multiple Myeloma Program: A Multicenter, Real-World Evidence Generation Network
Authors: Shaji Kumar, William A. Wood, Kenneth C. Anderson, Emily A. Semmel, Shandra James, Donna S. Neuberg, Kathleen Hewitt, Mark A. Schroeder, David J. Chung, Aaron S. Rosenberg, Jeffrey A. Zonder, Samuel M. Rubinstein, Anita D'Souza, Thomas Martin, Ajai Chari, Ravi Vij, Ajay K. Nooka, Manisha Bhutani, Peter M. Voorhees, Adam S. Sperling, Susan M. Geyer, Michael W. Craige, Sam Walters, Andriy Derkach, Saad Z. Usmani
Journal: Blood (2024)
Diagnostic Utility of the 18f-FDG PET/CT Scan in Solid Organ Transplant Patients with EBV Reactivation at Risk for Post-Transplant Lymphoproliferative Disorder
Authors: Hua-Jay J Cherng, Rebecca Scalabrino, Patrick Gould, Alexander Sanjurjo, Brian Cuzzo, Saagar Jain, Hong Y Ma, Maegan Ford, Evelyn H. Orlando, Dorine De Jong, Manuela A Orjuela, Andrew H. Lipsky, Seda S. Tolu, Barbara Pro, Jennifer E. Amengual, Kathleen M Capaccione
Journal: Blood (2024)
Molecular Mechanisms Associated with Autophagy Inhibition to Overcome Resistance to FLT3 Inhibitors
Authors: Manuela Albuquerque De Melo, Diego A. Pereira-Martins, Brunno Gilberto Santos Macedo, Livia Bassani Lins de Miranda, Priscila Santos Scheucher, Isabel Weinhäuser, Gerwin Huls, Jan Jacob Schuringa, João Agostinho Machado-Neto, Fabiola Traina
Journal: Blood (2024)
A First-in-Human Phase 1/2 Study of the Menin-KMT2A(MLL1) Inhibitor BN104 in Adult Patients with Relapsed or Refractory Acute Leukemia
Authors: Depei Wu, Ying Wang, Suning Chen, Yuhua Li, Rui Huang, Jinhai Ren, Xiaoling Guo, Yan Li, Mingyuan Sun, Xudong Wei, Ruihua Mi, Xiaoyu Zhu, Anyou Wang, He Huang, Yi Luo, Dengju Li, Jin Yin, Xiaojing Yan, Ran Gao, Fei Li, Yu Wang, Bryan Huang, Ye Hua
Journal: Blood (2024)
Inhibition of Peroxisome Proliferation-Activated Receptor Delta (PPARδ) Selectively Kills Acute Myeloid Leukemia Cells
Authors: Yingying Yang, Ekaterina Parfenova, Nikolina Vrdoljak, Mark D. Minden, Jessica Luc, Andrew Doxey, Paul A. Spagnuolo
Journal: Blood (2024)
Outcomes of Patients with Refractory and Relapsed Primary Mediastinal B Cell Lymphoma: A Canadian Single-Center Analysis
Authors: Rintu Sharma, John Kuruvilla, Michael Crump, David Hodgson, Yangqing Deng, Abi Vijenthira, Vishal Kukreti, Robert Kridel, Rodger E Tiedemann, Sita Bhella, Chloe Yang, Anca Prica
Journal: Blood (2024)
Safety Profile of Infectious Events for First-Line Pola-R-CHP Therapy in Elderly Patients with Diffuse Large B-Cell Lymphoma Including Those 80+ Years Old in Japan
Authors: Yo Saito, Tetsuro Oda, Shimpei Nakanishi, Minoru Ota, Naoki Maeda, Daisuke Kozuka, Noriko Fukuhara
Journal: Blood (2024)
Impact of Late Relapses in the Outcome of Childhood Acute Lymphoblastic Leukemia <i>IKZF1</i>del and <i>IKZF1</i>plus: An Update Findings Previously Reported
Authors: Maria Sara Felice, Patricia Laura Rubio, Jorge Gabriel Rossi, Jorge Digiorge, Elisa Olga Sajaroff, Myriam Ruth Guitter, Carla Luciana Pennella, Luisina Peruzzo, Cristian German Sánchez La Rosa, Hernan Zamaro, Elizabeth Alfaro
Journal: Blood (2024)
A Prospective Clinical Study of Venetoclax Plus Azacitidine for the Maintenance Treatment of Post-Remission Acute Myeloid Leukemia
Authors: Weiming Li, Fang Cheng, Jing Zou, Yuanyan Tang, Haiyan Wang, Jie Tan, Qihuan Liu, Hongbo Ren, Meifang Su, Hongxiang Wang, Zhuangzhi Yang, Lulu Zhang, Renying Ge, Jing He, Chuancai Liu, Jun Qin, Jing Zheng, Zhe Zhao
Journal: Blood (2024)
BMS-986397, a First-in-Class Molecular Glue Degrader of Casein Kinase 1α (CK1α) for the Treatment of Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS) Harboring Functional TP53
Authors: Carmen Jimenez, Sophie Peng, Rama Krishna Narla, Joshua Baughman, Scott Wood, Jean Lu, Noelia Purroy, Gina Yanochko, Mark Nagy, Gang Lu, Mark Rolfe, Daniel W. Pierce, Soraya Carrancio
Journal: Blood (2024)
Dynamic Assessment of RBC-Transfusion Dependency (RBC-TD) Improves the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification of MDS
Authors: Thomas Wiseman, Michaela Spooner, Shreyas Khanna, Kevin Hung, Carla Toop, Deepak Singhal, David M Ross, David T Yeung, Anna Brown, Hamish S Scott, Christopher N. Hahn, Daniel Thomas, Chung How Kok, Devendra Hiwase
Journal: Blood (2024)
Impact of Absolute Lymphocyte Counts (ALC) on Outcomes Following Bispecific Antibody Therapy in Patients with Relapsed/Refractory Multiple Myeloma Patients: A Single Center Real-World Experience
Authors: Yash Shah, Mark Fiala, Keith Stockerl-Goldstein, Mark A. Schroeder, Ravi Vij, Zachary D. Crees, Michael Slade
Journal: Blood (2024)
Identification of Ikaros As Novel Interaction Partner of Cyclin D1/CDK4 in MCL
Authors: Xiaoyang Sun, Stephan de Bra, Tatjana Schmitz, Stefan Tholen, Geoffroy Andrieux, Uta Sabine Sabine Martens, Melanie Boerries, Oliver Schilling, Justus Duyster, Cornelius Miething
Journal: Blood (2024)
Belantamab Mafodotin Plus Pomalidomide and Dexamethasone Vs Pomalidomide Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Subset Analysis in Patients Who Have Received 1 Prior Line of Therapy Including Lenalidomide
Authors: Meral Beksac, Esther Gonzalez Garcia, Sosana Delimpasi, Pawel Robak, Kamaraj Karunanithi, Felipe De Arriba, Jakub Radocha, Kihyun Kim, Sergey Voloshin, Vera Zherebtsova, Iurii Osipov, Maria-Victoria Mateos, Syed F. Zafar, Luděk Pour, Ivan Spicka, Kazuhito Suzuki, Xin Du, Jodie Wilkes, Brijesh Maroj, Kristin Morris, Jie Ma, Margaret Polinkovsky, Zhaohui Wang, Xiaoou L Zhou, Giulia Fulci, Neal Sule, Brandon Kremer, Joanna Opalinska, Suzanne Trudel, Meletios A. Dimopoulos
Journal: Blood (2024)
Advancing Patient-Centered Care to Overcome Health Disparities in Multiple Myeloma: Key Findings from a Quality Improvement Initiative
Authors: Joseph Mikhael, Cesar Rodriguez, Amy E. Pierre, M. Sarfraz Nawaz, Ellie Moses-Okwei, Lindsay Gurska, Emily Zyborowicz, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen
Journal: Blood (2024)
Patient Preferences on Clinical Decision-Making in Myeloma: A 747-Patient Survey
Authors: Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Katherine Berger, Ryan Winborg, Mason S. Barnes, Jorge Arturo Hurtado Martinez, Jay R. Hydren, Douglas W Sborov, Amandeep Godara, Brian McClune, Christopher Booth, Edward R Scheffer Cliff
Journal: Blood (2024)